Related Experiment Video
Updated: Mar 12, 2026

08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.7K
Expression and function of PIM kinases in osteosarcoma.
Shuai Mou1, Guangbin Wang1, Ding Ding2
1Department of Orthopaedics, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, P.R. China.
International Journal of Oncology
|November 10, 2016
Summary
PIM kinases are frequently expressed in osteosarcoma (OS). PIM1 expression indicates poorer prognosis, and PIM kinase inhibition may offer new therapeutic strategies for OS patients.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- The PIM (provirus integrating site Moloney murine leukemia virus) kinase family, comprising PIM1, PIM2, and PIM3, are serine/threonine protein kinases implicated as oncoproteins in various cancers.
- The specific role and clinical significance of PIM kinases in osteosarcoma (OS) pathogenesis are not well-established.
Purpose of the Study:
- To investigate the expression patterns of PIM1, PIM2, and PIM3 in human osteosarcoma.
- To evaluate the clinical significance of PIM kinase expression in relation to patient prognosis.
- To determine the biological effects of PIM kinase modulation on osteosarcoma cell behavior.
Main Methods:
- Immunohistochemical staining was employed to assess PIM kinase expression in 43 primary osteosarcoma tissue samples.
- Functional studies involved PIM kinase knockdown and overexpression in human osteosarcoma cell lines to analyze effects on proliferation, migration, and invasion.
Main Results:
- All three PIM kinases (PIM1, PIM2, PIM3) were frequently detected in osteosarcoma tissues.
- Positive PIM1 expression correlated significantly with poorer overall survival in osteosarcoma patients.
- PIM kinase inhibition markedly reduced osteosarcoma cell proliferation, migration, and invasiveness.
- Conversely, PIM kinase overexpression led to enhanced osteosarcoma cell growth and motility.
Conclusions:
- PIM1 may serve as a valuable prognostic biomarker for osteosarcoma patients.
- The PIM kinase family plays a significant role in osteosarcoma cell biology, suggesting their potential as therapeutic targets for this malignancy.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
6.1K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
6.1K
mTOR Signaling and Cancer Progression
5.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
5.0K
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Interactions Between Signaling Pathways
7.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.7K
The JAK-STAT Signaling Pathway
13.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.6K
MAPK Signaling Cascades
9.0K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.0K

